BioWorld

May 14, 2002

Athersys Raises $16.2M Privately To Continue Multiple Programs

Athersys Inc. completed a private placement totaling $16.2 million to be used to continue about a dozen projects, which focus on oncology, the central nervous system and inflammation. (BioWorld Today) Read More

Phylos, Avalon Using PROfusion To Identify Drug-Protein Targets

Natural Killer Cell Subset Skulks Doggo For Years During HAART Drug Treatment, Then Breaks Out

Biosynexus Pushing Ahead With Protein-Based Platforms

Other News To Note

Quarterly Earnings Reports

Today's news in brief

BioWorld

BioWorld briefs for Dec. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

In 2025, science’s biggest story was political

BioWorld

In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...

Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis

BioWorld Science

Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...